Ghent University Academic Bibliography

Advanced

A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.

M LAMOTTE, Lieven Annemans UGent, A LEFEVER, M NECHELPUT and J MASURE (2002) DIABETES CARE. 25(2). p.303-308
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
DIABETES CARE
Diabetes Care
volume
25
issue
2
pages
303-308 pages
Web of Science type
Article
Web of Science id
000173522600008
JCR category
ENDOCRINOLOGY & METABOLISM
JCR impact factor
5.477 (2002)
JCR rank
11/88 (2002)
JCR quartile
1 (2002)
ISSN
0149-5992
language
English
UGent publication?
yes
classification
A1
id
165892
handle
http://hdl.handle.net/1854/LU-165892
date created
2004-01-14 13:40:00
date last changed
2016-12-19 15:38:24
@article{165892,
  author       = {LAMOTTE, M and Annemans, Lieven and LEFEVER, A and NECHELPUT, M and MASURE, J},
  issn         = {0149-5992},
  journal      = {DIABETES CARE},
  language     = {eng},
  number       = {2},
  pages        = {303--308},
  title        = {A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.},
  volume       = {25},
  year         = {2002},
}

Chicago
LAMOTTE, M, Lieven Annemans, A LEFEVER, M NECHELPUT, and J MASURE. 2002. “A Health Economic Model to Assess the Long-term Effects and Cost-effectiveness of Orlistat in Obese Type 2 Diabetic Patients.” Diabetes Care 25 (2): 303–308.
APA
LAMOTTE, M., Annemans, L., LEFEVER, A., NECHELPUT, M., & MASURE, J. (2002). A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. DIABETES CARE, 25(2), 303–308.
Vancouver
1.
LAMOTTE M, Annemans L, LEFEVER A, NECHELPUT M, MASURE J. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. DIABETES CARE. 2002;25(2):303–8.
MLA
LAMOTTE, M, Lieven Annemans, A LEFEVER, et al. “A Health Economic Model to Assess the Long-term Effects and Cost-effectiveness of Orlistat in Obese Type 2 Diabetic Patients.” DIABETES CARE 25.2 (2002): 303–308. Print.